Encephalomyocarditis and influenza viruses attach to human erythrocytes causing haemagglutination. The receptor for both viruses on these cells is the major membrane sialoglycoprotein, glycophorin, solubilized preparations of which inhibit haemagglutination by either virus. We show here that glycophorin preparations inhibited haemagglutination of both viruses, even after the preparations were digested with chymotrypsin. To determine which component(s) in the digest exhibited activity, peptides separated by gel filtration were assayed for haemagglutination inhibition; one peptide only, CH-0, was active. A tentative structure was deduced for CH-0 from amino acid and sialic acid analyses. It was already known that neuraminidase treatment of erythrocytes or glycophorin prevents interaction with either virus, suggesting that sialic acid may form part of the active binding site in the receptor. However, receptor activity requires more than the presence of a particular arrangement of sialic acid since the arrangement in CH-0 was identical to that in two other inactive chymotryptic peptides. Examination by gel filtration, sucrose density gradient centrifugation and SDS-polyacrylamide gel electrophoresis demonstrated that CH-0 readily aggregated, unlike the inactive peptides. It was proposed that the CH-0 chymotryptic peptide showed receptor-like activity (inhibited haemagglutination) because its tendency to aggregate allowed strong multivalent binding with virus particles.
INTRODUCTION
Glycophorin, the major sialoglycoprotein in the human erythrocyte surface membrane (Fairbanks et al., 1971 ; Marchesi et aL, 1976) , can serve as a receptor for both influenza virus (Kathan et al., 1961 ; Marchesi & Andrews, 1971 )and for encephalomyocarditis (EMC) virus (Enegren & Burness, 1977) . We have shown previously that tryptic digests of glycophorin interacted with both viruses as efficiently as undigested glycophorin (Burness & Pardoe, 1981) . This suggested that fragments of glycophorin can behave as soluble receptors and gave rise to the hope that characterization of the fragments would bring closer an understanding of the fine structure of the active site for virus binding. The present investigation was undertaken to identify the active fragment(s) in glycophorin digests. Chymotrypsin rather than trypsin was used to generate fragments since chymotryptic peptides of glycophorin differ more from each other in size and are easier to separate than their tryptic counterparts (Tomita et al., 1978) .
Amino acid analyses. These were performed in a Beckman Model 121 MB analyser on samples containing 0.45 to 0-75 mg protein hydrolysed at 110 °C for 24 h in 6 M-HCI.
Haemagglutination (HA) inhibition. Serial twofold dilutions of glycophorin or its chymotryptic peptides
containing 200 Bg protein/ml in phosphate-buffered saline (PBS) were made on microtitre plates. To each microtitre well was then added an equal volume (50 ~tl) of either EMC or influenza virus (8 HA units) followed by 50 ~tl 0.2~ human red blood cells in 50~o PBS containing 0.1 ~o gelatin-50~o 4.5~ (w/v) glucose. Endpoints, recorded after keeping the microtitre trays at 4 °C overnight, were used to calculate the number of HA units of virus inhibited by 1 ~tg protein.
Sucrose gradient sedimentation. Samples were centrifuged on 10 to 30~ sucrose gradients in 0-02 M-phosphate buffer pH 8 containing 0.1 M-NaC1 and also, in some experiments, 0.1 ~ SDS, in a Beckman SW50.1 rotor at 50000 rev/min for 6-5 h or, in SDS, for 22 h. Each tube contained 10 mg bovine serum albumin as a marker. Fractions of about 0-3 ml were collected, diluted with water to I ml for absorbance measurements at 280 nm and for radioactivity measurements.
RESULTS

Effect of chymotrypsin on erythrocytes
Incubation of human erythrocytes with trypsin has no effect or enhances their haemagglutination by EMC or influenza viruses (Burness & Pardoe, 1981 ; Enegren & Burness, 1977) . To determine whether this was also true of chymotrypsin, human erythrocytes were incubated in the presence or absence of chymotrypsin for various lengths of time. The amount of sialic acid in the sialoglycopeptides released into the supernatant fluid was used to follow the course of the digestion of the sialoglycoprotein in the erythrocyte surface. Assuming that hydrolysis of membranes with 0.05 M-H2SO 4 at 80 °C for 1 h releases 100~ of the sialic acid (Burness & Pardoe, 1981) , incubation with chymotrypsin released 38~ of the total sialic acid after 1 h, 48~o after 2 h and 73~ after about 18 h (Fig. I) .
Despite the loss of sialic acid from the cell surface, there was little effect on virus attachment to the cells which was measured in two ways. In the first method, the enzyme-treated erythrocytes were themselves used for haemagglutination assays. This method gave identical HA titres for erythrocytes incubated in the presence or absence of chymotrypsin whether EMC or influenza virus was tested, even after overnight incubation of cells with enzyme (result not shown). In the second method, enzyme-treated and control cells were incubated with EMC or influenza virus for 1 h to allow virus to adsorb; the cells were collected by centrifugation and the loss of virus from the supernatant fluid was measured by haemagglutination assays using untreated cells. This second procedure showed that cells incubated with chymotrypsin were as effective as non-enzyme-treated cells in binding virus, although overnight incubation of cells with enzyme, while having no effect on influenza virus attachment, reduced EMC virus attachment to 50~ of controls (Fig. 1) . The loss of sialoglycopeptides into the supernatant fluid was accompanied, as expected, by a reduction in the size of the sialoglycoproteins associated with the ceils. This was shown by analysis of membranes prepared from enzyme-treated and control cells by electrophoresis on 5"6~o polyacrylamide gels. Human erythrocyte membranes contain the components PAS-1 to PAS-4 (Burness & Pardoe, 1981; Enegren & Burness, 1977; Steck, 1974) . Changes in these components were obvious within minutes of adding the chymotrypsin to cells (compare Fig. 2a and b) and after 4 h incubation the original components were converted almost completely to lower tool. wt. components (result not shown).
Receptor-active sialoglycopeptide for viruses
Effect of chymotrypsin on glycophorin
Glycophorin preparations were incubated in the presence or absence of chymotrypsin for various lengths of time after which the samples were cooled in ice before measuring their HA inhibitory properties (Table 1) . Incubation of glycophorin with enzyme for up to 4 h had no marked effect on its HA inhibitory properties against EMC virus which varied in this experiment from 50 to 200~o of controls, a variation not uncommon with an assay like HA inhibition which uses doubling dilutions. Chymotrypsin digestion of glycophorin apparently caused a reduction in its inhibition of influenza virus HA between 40 and 75~ of controls in this particular experiment, a change which was marginally significant at the most. The conclusion was, therefore, that chymotrypsin digestion of glycophorin had little effect on its HA inhibitory properties against either virus.
To confirm that chymotrypsin was active against glycophorin, digests were examined by electrophoresis on 5.6 ~ polyacrylamide gels. As described previously (Burness & Pardoe, 1981 ; Enegren & Burness, 1977; Steck, 1974) , undigested glycophorin preparations consisted predominantly of PAS-1 and PAS-2, the dimer and monomer forms of glycophorin A Marton & Garvin, 1973) , together with small amounts of PAS-3 and PAS-4 (Fig. 2c ). Preparations incubated with chymotrypsin for as little as 15 min, the shortest incubation time examined, produced a markedly different SDS-gel electrophoretic profile compared with undigested material in that PAS-1 and PAS-2 were greatly diminished and a component of mobility between that of PAS-2 and PAS-3 became evident (result not shown). The changes were more pronounced by 1 h by which time PAS-1 and PAS-2 were barely detectable being replaced by three components with greater mobility (Fig 2d) . These three components survived incubation with chymotrypsin for more than 18 h, the only change noted being an increase in the amount of the middle component at the expense of the slowest moving component of the three (result not shown). Glycophorin incubated for 18 h in the absence of chymotrypsin had an electrophoretic profile indistinguishable from the original unincubated glycophorin (result not shown).
Separation of glycophorin chymotryptic peptides by gel filtration
Glycophorin was digested with chymotrypsin for 18 h then assayed for HA inhibitory activity and examined by gel filtration. The material eluted in six peaks from Sephadex G-150 using absorbance at 230 nm for detection (Fig. 3) , five of the peaks corresponding to peptides CH-1 to CH-5 reported previously (Tomita et al., 1978) based on elution position and, as will be shown below, on amino acid composition. The sixth peak, CH-0, which eluted close to the void volume was not reported previously (Tomita et al., 1978) , although a sixth peptide, CH-6, was described which, being insoluble, was removed by centrifugation before gel filtration was attempted both in the studies reported here and in previous studies (Tomita et al., 1978) . Detection of the peptides by u.v. absorption measurements was not a particularly sensitive method for analysis of gel filtration eluates and, therefore, other detection methods were investigated. We have shown previously that glycophorin can be conveniently labelled with [3H]acetic anhydride (Pardoe & Burness, 1980) . Gel filtration of 3H-acetylated glycophorin digests revealed that all peptides except CH-5 were radioactive, although CH-3 was of low specific radioactivity (Fig. 3) . Peptides CH-3 and CH-5 lack lysine (Fig. 5) , the amino acid predominantly acetylated by acetic anhydride at neutral pH, although hydroxyls in serine and, to a slight extent, tyrosine are occasionally attacked (Fraenkel-Conrat, 1962) . Despite the low level of radioactivity in CH-3, 3H-acetylated glycophorin was frequently used in the present studies since, when combined with u.v. absorbance measurements, it facilitated identification of the individual chymotryptic peptides.
More recently we have found that labelling of glycophorin with 131i gave a product which had very high specific radioactivity (3 x 107 ct/min/pg protein). Peptides CH-0 to CH-3 were readily labelled by this method, while peptides CH-4 and CH-5 which lack tyrosine (Fig. 5) were unlabelled (Fig. 3) . 131Iodination therefore promises to be a useful method for future studies since peptides CH-0 to CH-3, unlike CH-4 and CH-5, are glycosylated (Fig. 5) and are thus the peptides of most interest when looking for fragments with receptor-like activity for EMC and influenza viruses.
The fractions comprising each of peaks CH-0 to CH-5 derived from 3H-labelled glycophorin were combined, lyophilized to remove the ammonium acetate used for gel filtration and the biological, chemical and physical properties of the six components examined further as described next.
Biological properties of the individual chymotryptic peptides
To determine which component(s) in chymotryptic digests was responsible for HA inhibition, each of the peptides separated by gel filtration was adjusted to approximately the same protein concentration and tested for biological activity ( Table 2) Chymotryptic peptides separated by gel filtration (Fig. 3) were analysed on sucrose gradients by centrifugation at 234000 g (a to d) for 6-5 h in the absence or (e to h) for 22.5 h in the presence of 0.1 SDS. Sedimentation is from left to right. Fractions were examined for absorbance at 280 nm to detect the bovine serum albumin marker (©), and for radioactivity (0). P indicates pellet at bottom of centrifuge tube. Sample Original glycophorin Chymotryptic digest CH-0 CH-1 to CH-5 chymotryptic peptides, only component CH-0 showed HA inhibition. On a weight for weight basis, CH-0 was more active than the original, undigested or the digested glycophorin. In contrast, peptides CH-1 to CH-5 were completely inactive within the limits of detection of HA inhibition measurements.
Chemical nature of chymotryptic peptides
Peptides CH-1, CH-2 and CH-3 were expected to be sialoglycopeptides by comparison with previous results (Tomita et al., 1978) . This was confirmed by sialic acid assays which also , 1978) . CH-0 is thought to be produced by failure to cleave bonds between amino acids :64 and 65 and between 98 and 99. *, Sialo-oligosaccharide side chains; T, bonds cleavable by chymotrypsin.
showed that CH-0 contained siatic acid and that CH-4 and CH-5 contained small amounts, possibly arising from contaraination with the early eluting sialoglycopeptides (Table 3) . The amino acid compositions of peptides CH-0, CH-1, CH-2 and CH-3 were determined (Table 3) . Under the analytical conditions used, galactosamine which is present in glycophorin (Thomas & Winzler, 1969 ) co-eluted with valine which therefore could not be quantified. These amino acid analyses were single determinations on column peaks which had not been purified further following chromatography. Under the circumstances, it was satisfying that the amino acid residues calculated for CH-1, CH-2 and CH-3 were in most cases identical to those reported previously (Tomita et al., 1978) ; they are given in parentheses in Table 3 .
There are several differences in the amino acid composition of CH-0 compared with CH-1, CH-2 and CH-3, the most noteworthy difference being the presence of phenylalanine which is absent from the latter three peptides (Table 3) .
Physical properties of chymotryptic peptides
Separation of substances by gel filtration is related to their molecular size (Andrews, 1964) . Having identified CH-I, CH-2 and CH-3 from their amino acid composition, their mol. wt. can be calculated from their reported chemical composition (Tomita et al., 1978) . The elution volume of CH-0 from Sephadex (Fig. 3) (9) 2-6 (2) Pro 6-0 3-2 (3) - § (0) 3-0 (3) Glu 4-9 7.7 (8) 2-3 (1) 3-0 (7) Gly 6-1 2.0 (2) 1.2 (1)
2.8 (3) 1.9 (2) 2-4 (3) Arg 3-2 3.6 (4) 0.9 (1) 2.4 (3) Sialic acidlt 0.30 1.28 1.11 0-57 0.03 0-01 * Amino acid data expressed as relative molar ratios based on phenylalanine as 2 for CH-0, and isoleucine as 2, 1 and 1 respectively for CH-1, CH-2 and CH-3.
t Number in parentheses are expected values, taken from Tomita et al. (1978) .
:~ No entry indicates no determination or, in the case of valine, result erroneous due to co-elution with galactosamine.
§ -denotes 0.1 residue or less. lJ Expressed as mg sialic acid per mg protein. * Calculated from published chemical composition (Tomita et al., 1978) .
used to estimate an apparent mol. wt. for CH-0 of at least 64000, which was a minimum figure since CH-0 eluted very close to the void volume. Chymotryptic digests of glycophorin were also examined by electrophoresis on 12-5% polyacrylamide gels containing 0-1% SDS and 8 M-urea (Swank & Munkres, 1971) . Undigested glycophorin ran predominantly in the dimer form (i.e. PAS-1) on these gels and penetrated a short distance only (Fig. 2e) . Chymotryptic peptides were well separated from each other (Fig.  2f) and from their mobilities estimates were made of their apparent mol. wt. by comparison with the mobilities of mol. wt. markers run on parallel gels. The values obtained for CH-I, CH-2 and CH-3 were in reasonable agreement with mol. wt. calculated from their composition (Table  4 ). CH-0 had an apparent mol. wt. of 30000 which was less than half that obtained by gel filtration in the absence of detergents.
Tests for biological activity of glycophorin and its chymotryptic peptides were conducted in PBS. Therefore, it was considered necessary to get some idea of the nature of the peptides in physiological solution rather than in the SDS used for electrophoresis or the ammonium acetate used for chromatography. For this purpose, rate zonal ultracentrifugation on sucrose gradients for 6-5 h was used. Under these conditions, 3H-acetylated CH-1, CH-2 and CH-3 behaved as expected for peptides of their size (Table 4 ) and hardly sedimented into the gradient (Fig. 4b to Receptor-active sialoglycopeptide for viruses 1145 d); in contrast, CH-0 was apparently aggregated since all of the radioactivity sedimented to the bottom of the tube (Fig. 4a) . The sucrose density gradient centrifugations were repeated in the presence of SDS. Under these conditions, peptides CH-1, CH-2 and CH-3 again behaved as small molecules and sedimented as single peaks (although peak CH-3 may have a shoulder) ( Fig.  4f to h ) and this time CH-0 no longer sedimented in an aggregated form, but also sedimented as a single peak (Fig. 4e) .
DISCUSSION
The purpose of the work described in this report was to identify the peptide(s) with receptorlike (HA inhibitory) properties for EMC and influenza viruses in chymotryptic digests of glycophorin. It was found early in the study that the HA inhibitory activity was a property of one peptide, CH-0. Since CH-0 had not been characterized previously, the study was extended to elucidate the structure of CH-0 and to explain why it alone of the chymotryptic peptides had biological activity.
The amino acid sequence and location of the sialo-oligosaccharide side chains in glycophorin are known (Fig. 5a ). Also known are the four bonds cleaved by chymotrypsin to give the wellcharacterized peptides CH-2 to CH-6; sometimes, the bond between CH-2 and CH-3 remains uncleaved giving rise to peptide CH-1 (Figs. 5b) . Attempts to work out the structure of CH-0 assumed that cleavage had occurred at no bond other than at one, or more, of these four. Since CH-0 was found to be larger than any of the peptides CH-I to CH-6, it was considered to be made up of some combination of them.
Characterization of CH-0 was difficult, firstly because the amount found in chymotryptic digests varied, possibly because of the second difficulty which was that CH-0 was not particularly soluble in simple aqueous solvents. Nevertheless, with the availability of extensive information on the structure of glycophorin and its chymotryptic peptides, sufficient information was gathered to suggest that CH-0 had the structure: CH-3-CH-6. CH-4 (Fig. 5 b) . The evidence for this is as follows.
(i) Evidence that the sequence for CH-0 includes CH-3. CH-0 contained sialic acid (Table  3) . Therefore, it must have included within its structure the sialoglycopeptides CH-2 and/or CH-3. The ratio of sialic acid to protein in CH-0 is about 0-3 (Table 3) . Since any peptide containing CH-2, which is rich in sialic acid, would have a ratio of 0.67 or higher, clearly CH-2 was not present in CH-0. In fact, the only possible polypeptides with ratios close to 0.3 are CH-3-CH-6-CH-4 (ratio 0.27) and CH-3. CH-6 (ratio 0.35). These two peptides can be distinguished by amino acid analysis as discussed next.
(ii) Evidence that CH-0 contains CH-4. The peptide CH-3-CH-6 would contain neither aspartic acid nor lysine (Fig. 5a ). In contrast, both CH-4 (Tomita et al., 1978) and CH-0 both contain three residues of each, indicating that the structure for CH-0 cannot be CH-3. CH-6 but could be CH-3. CH-6-CH-4.
(iii) Evidence that CH-0 contains CH-6. If CH-0 contains CH-3 and CH-4, it must also contain CH-6, which is located between them in glycophorin (Fig. 5b) . Direct evidence to support this also came from amino acid analyses. Peptide CH-6 encompasses the only region in glycophorin containing phenylalanine (amino acids 68 and 78) and the same region contains one of the two methionine residues (amino acid 81) in glycophorin. Since CH-0 also contained two phenylalanines and one methionine (Table 3) , it is clear that CH-6 was present.
Further evidence that CH-0 has the structure CH-3-CH-6-CH-4 is provided by the similarity in overall amino acid composition to that predicted knowing the individual compositions for CH-3, CH-4 and CH-6 (Table 5) . Although the composition found for CH-0 differed slightly from that predicted, this can be expected since the compositions we found for CH-1, CH-2 and CH-3, although close to, were not identical to those published previously (Tomita et al., 1978) . The most worrisome differences between the amino acid composition of CH-0 and that predicted for CH-3-CH-6-CH-4 was in the apparent deficiency of proline and glutamic acid in CH-0. However, the value we found for glutamic acid in CH-3 was also much lower than previously reported values (Tomita et al., 1978) . Attempts to construct on paper a polypeptide of composition closer to that found for CH-0 by considering cleavages of bonds not normally
